Korea MFDS Introduces New Self-Testing IVD Categories for Influenza and Drugs of Abuse
The Ministry of Food and Drug Safety (MFDS)
amended the Regulation on IVD Medical Device Items and Item Classification
(Notification
No. 2026-45) on June 30, 2026, establishing two new categories of
self-testing in vitro diagnostic medical devices (IVDs) for influenza and drugs
of abuse.
The amendment expands public access to
self-testing IVDs by broadening the scope beyond the existing nine self-testing
IVD categories, including those for pregnancy, blood glucose, and COVID-19. The
newly introduced influenza self-test kit is expected to enable rapid
identification of infected individuals during the early stages of infection,
helping to reduce disease transmission. In addition, the drugs of abuse
self-test kit will allow individuals to quickly determine whether they have
been unintentionally exposed to illicit drugs, supporting timely and
appropriate responses.
The newly established self-testing IVD
categories are as follows.
• K05070.01 IVD reagents for self
testing of Influenza virus or SARS-CoV-2 using immunological method (Class 3) -
Effective June 30, 2026
• K06060.01 IVD reagents for self
testing of drugs of abuse (Class 2) - Effective June 30, 2028
GCA Korea provides expert support for global companies navigating Korea’s regulatory requirements, including KC Certification.
Our expertise covers KC EMC, KC Safety, KC Energy Efficiency, KC Automotive Components, KCsEx (ATEX, IECEx), and MFDS (Korean Medical Devices).

Comments
Post a Comment